Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.
about
A role for G-CSF and GM-CSF in nonmyeloid cancersIntratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.Antitumor activity of a polypyridyl chelating ligand: in vitro and in vivo inhibition of glioma.A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays.Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model.Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomasExperimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.Enhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide.
P2860
Q27002515-60A1E7E9-AF1B-4462-A03C-8AE88E0EC947Q34775318-F270EC6B-4AA3-4624-98A3-D80CF10BE7E0Q35196720-D450C0CF-81D4-43D7-96E8-9B8D094D51C0Q35860191-CE7DEAD9-2A8C-4FEC-929F-D39A9CFFC349Q36416387-ED4C35D4-2711-4362-8C18-21C71E210D3DQ37658308-4E87F6ED-45B4-4D3C-A161-89AB28931C1FQ37814208-CC94B834-2BAB-4A36-8F5C-816844396E6AQ48379910-7A8637C8-5E64-4AF8-A8F3-CBCA9B1D7D0A
P2860
Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cure of established GL261 mous ...... by both CD8+ and CD4+ T-cells.
@ast
Cure of established GL261 mous ...... by both CD8+ and CD4+ T-cells.
@en
type
label
Cure of established GL261 mous ...... by both CD8+ and CD4+ T-cells.
@ast
Cure of established GL261 mous ...... by both CD8+ and CD4+ T-cells.
@en
prefLabel
Cure of established GL261 mous ...... by both CD8+ and CD4+ T-cells.
@ast
Cure of established GL261 mous ...... by both CD8+ and CD4+ T-cells.
@en
P2093
P356
P1476
Cure of established GL261 mous ...... by both CD8+ and CD4+ T-cells.
@en
P2093
Anna Darabi
Edward Visse
Karin Enell Smith
Sara Fritzell
Shorena Janelidze
Sofia Eberstål
Wiaam Badn
P2860
P304
P356
10.1002/IJC.23986
P50
P577
2009-02-01T00:00:00Z